What empiric antibiotics should be used for a suspected nasal skin infection?

Empiric Antibiotic Treatment for Nasal Skin Infections

For suspected nasal skin infections, empiric antibiotic therapy should target both Staphylococcus aureus (including MRSA) and Streptococcus pyogenes, with the specific regimen determined by infection severity and local MRSA prevalence.

Severity-Based Treatment Algorithm

Mild Infections (No Systemic Signs)

For simple furuncles or small abscesses (<5 cm erythema, temperature <38.5°C, WBC <12,000, pulse <100):

• Incision and drainage alone is sufficient without antibiotics 1
• If antibiotics are deemed necessary due to patient factors, use oral agents active against MRSA:
  • First-line oral options: TMP-SMX, doxycycline, or linezolid 1, 2
  • Duration: 5-7 days 1

Moderate Infections (Systemic Signs Present)

For cellulitis with fever >38.5°C, heart rate >110, or erythema >5 cm:

• If no MRSA risk factors: Use agents targeting streptococci

  • Cephalexin 500 mg every 6 hours PO
  • Cefazolin 0.5-1 g every 8 hours IV 1

• If MRSA risk factors present (prior MRSA infection, nasal colonization, injection drug use, recent antibiotics, purulent drainage):

  • Oral: TMP-SMX or doxycycline PLUS a beta-lactam (amoxicillin or cephalexin) for dual coverage 2
  • IV: Vancomycin 15 mg/kg every 12 hours 1
  • Alternative IV options: Linezolid, daptomycin 10 mg/kg daily, or ceftaroline 2

Severe Infections (SIRS, Hemodynamic Instability, or Suspected Necrotizing Infection)

Broad-spectrum coverage is mandatory:

• Vancomycin or linezolid PLUS piperacillin-tazobactam 1
• Alternative: Vancomycin plus a carbapenem (imipenem/meropenem) 1
• Immediate surgical consultation required 1

Critical MRSA Risk Factors to Assess

The nasal area has high MRSA colonization rates. Consider MRSA coverage if:

• Prior MRSA infection or known colonization 1
• Recent antibiotic use (especially quinolones/macrolides) 2
• Injection drug use
• Incarceration history
• Healthcare exposure
• Purulent drainage present 1

Key Clinical Pitfalls

Avoid these common errors:

• Do not use macrolides empirically—resistance is now very common in both S. aureus and streptococci 2, 3
• Do not prescribe oral antistaphylococcal penicillins (oxacillin/nafcillin) due to poor pharmacokinetics 4
• Do not extend treatment beyond 5-7 days unless clinical improvement is lacking 1
• Do not give antibiotics for simple abscesses <5 cm after adequate drainage 1

Duration of Therapy

5 days is recommended for most cases, extending only if infection has not improved 1. Recent evidence increasingly supports shorter durations to minimize resistance and adverse effects 5.

Special Consideration: Nasal Colonization

For recurrent nasal infections, consider decolonization after acute treatment:

• Intranasal mupirocin twice daily for 5 days
• Daily chlorhexidine washes
• Decontamination of personal items 1

The nasal vestibule's proximity to colonization sites makes this particularly relevant for preventing recurrence.